Summary of Classification and Labelling
Notified classification and labelling
General Information
814-271-5 |
(2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide |
1802148-05-5 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(Musculo-skeleta...)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(other:Musculo-s...)
(oral)
|
H373
|
Number of Aggregated Notifications: 1